PP01.80 A retrospective observational study to evaluate patient-reported outcomes (PROs) in patients with metastatic ALK+ non-small cell lung cancer (NSCLC) treated with ALK inhibitors
Year: 2024
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: Josh Biber, Yin Wan, Eric N. Churchill, Christopher G. Danes, Mark A. Socinski, Alexander I. Spira
Institutions: AdventHealth Orlando, Virginia Cancer Specialists
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4400452422